Works matching DE "TOLTERODINE"

Results: 131

The effect of tolterodine 4 and 8 mg on the heart rate variability in healthy subjects.

Published in:

World Journal of Urology, 2010, v. 28, n. 5, p. 651, doi. 10.1007/s00345-010-0513-y

By:

Schiffers, Maya;
Sauermann, Peter;
Schurch, Brigitte;
Mehnert, Ulrich

Publication type:

Article

Optimizing individual treatment outcomes in men with lower urinary tract symptoms using storage subscale score/total International Prostate Symptom Score (IPSS) as a new IPSS ratio.

Published in:

Turkish Journal of Medical Sciences, 2014, v. 44, n. 6, p. 1124, doi. 10.3906/sag-1209-86

By:

ALTINTAŞ, Serkan;
ACAR, İsmail Cenk;
ESKİÇORAPÇI, Saadettin Yılmaz;
ZÜMRÜTBAŞ, Ali Ersin;
BOLAT, Deniz;
TUNCAY, Ömer Levent;
SINIK, Mehmet Zafer

Publication type:

Article

Long-acting formulation of a new muscarinic receptor antagonist for the treatment of overactive bladder.

Published in:

Journal of Microencapsulation, 2013, v. 30, n. 2, p. 116, doi. 10.3109/02652048.2012.704950

By:

Teng, Lesheng;
Jiang, Chaojun;
Sun, Fengying;
Li, Chunmei;
Teng, Lirong;
Meng, Qingfan;
Lee, Robert J.;
Li, Youxin

Publication type:

Article

Comparison of the efficacy and complications of tolterodine and α-adrenergic receptor blockers in improving ureteral stent-related symptoms: A systematic review and meta-analysis.

Published in:

PLoS ONE, 2024, v. 19, n. 5, p. 1, doi. 10.1371/journal.pone.0302716

By:

Liu, Ming;
Liu, Shangjing;
Mao, Qiancheng;
Zou, Qingsong;
Cui, Yuanshan;
Wu, Jitao

Publication type:

Article

A Review of Anticholinergic Medications for Overactive Bladder Symptoms.

Published in:

MEDSURG Nursing, 2013, v. 22, n. 2, p. 119

By:

Felicilda-Reynaldo, Rhea Faye

Publication type:

Article

The impact of anticholinergics on cognitive function in patients with neurogenic lower urinary tract dysfunction: A narrative review.

Published in:

Indian Journal of Urology, 2024, v. 40, n. 2, p. 82, doi. 10.4103/iju.iju_352_23

By:

Welk, Blayne

Publication type:

Article

Structural investigation, molecular structure and molecular docking of solifenacin succinate, flavoxate hydrochloride and tolterodine tartrate anti-cholinergic drugs.

Published in:

Journal of Thermal Analysis & Calorimetry, 2018, v. 131, n. 2, p. 1345, doi. 10.1007/s10973-017-6592-x

By:

Attia, Ali K.;
Mohamed, Gehad G.;
Ahmed, Heba E.

Publication type:

Article

Efficacy and safety of combination therapy (desmopressin with tolterodine) in nocturnal enuresis in children: An institutional experience.

Published in:

Journal of Dr. YSR University of Health Sciences, 2024, v. 13, n. 2, p. 133, doi. 10.4103/jdrysruhs.jdrysruhs_69_23

By:

Bansal, Rajan;
Rahul, Nekkanti;
Qazi, Ifrah A.;
Pogula, Veda Murthy Reddy;
Reddy, Sandeep K.

Publication type:

Article

The Role of Mirabegron in Overactive Bladder: A Systematic Review and Meta-Analysis.

Published in:

Urologia Internationalis, 2014, v. 93, n. 3, p. 326, doi. 10.1159/000361079

By:

Wu, Tao;
Duan, Xi;
Cao, Chen-Xi;
Peng, Chuan-Du;
Bu, Si-Yuan;
Wang, Kun-Jie

Publication type:

Article

Mirabegron or tolterodine for the treatment of overactive bladder in Japan: Which drug is more cost‐effective as the first‐line treatment?

Published in:

International Journal of Urology, 2018, v. 25, n. 10, p. 863, doi. 10.1111/iju.13764

By:

Yamanishi, Yuriko;
Yamanishi, Tomonori;
Tajima, Hakujyu;
Ikeda, Shunya

Publication type:

Article

Anticholinergic burden in the Japanese elderly population: Use of antimuscarinic medications for overactive bladder patients.

Published in:

International Journal of Urology, 2018, v. 25, n. 10, p. 855, doi. 10.1111/iju.13758

By:

Yoshida, Masaki;
Kato, Daisuke;
Nishimura, Takuya;
Van Schyndle, James;
Uno, Satoshi;
Kimura, Tomomi

Publication type:

Article

Systematic review and meta‐analysis on the efficacy and tolerability of mirabegron for the treatment of storage lower urinary tract symptoms/overactive bladder: Comparison with placebo and tolterodine.

Published in:

International Journal of Urology, 2018, v. 25, n. 3, p. 196, doi. 10.1111/iju.13498

By:

Sebastianelli, Arcangelo;
Serni, Sergio;
Gacci, Mauro;
Russo, Giorgio I.;
Morgia, Giuseppe;
Kaplan, Steven A.;
McVary, Kevin T.;
Moncada, Ignacio;
Gravas, Stavros;
Chapple, Christopher

Publication type:

Article

Persistence and adherence to overactive bladder medications in Japan: A large nationwide real-world analysis.

Published in:

International Journal of Urology, 2017, v. 24, n. 10, p. 757, doi. 10.1111/iju.13422

By:

Kato, Daisuke;
Uno, Satoshi;
Van Schyndle, James;
Fan, Alan;
Kimura, Tomomi

Publication type:

Article

Comparison of vascularization and overall perfusion of the bladder wall between women with and without overactive bladder syndrome.

Published in:

Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-64532-0

By:

Hsiao, Sheng-Mou;
Shih, Jin-Chung;
Lee, Chien-Nan;
Lin, Ho-Hsiung

Publication type:

Article

Tolterodine to Relieve Urinary Symptoms Following Transurethral Resection of the Prostate: A Double-Blind Placebo-Controlled Randomized Clinical Trial.

Published in:

Korean Journal of Urology, 2014, v. 55, n. 4, p. 260, doi. 10.4111/kju.2014.55.4.260

By:

Tehranchi, Ali;
Rezaei, Yousef;
Shojaee, Reza

Publication type:

Article

Development of an Ion Chromatography Method for Analysis of Organic Anions (Fumarate, Oxalate, Succinate, and Tartrate) in Single Chromatographic Conditions.

Published in:

Scientia Pharmaceutica, 2015, v. 83, n. 4, p. 611, doi. 10.3797/scipharm.1503-15

By:

KAVIRAJ, Yarbagi;
SRIKANTH, B.;
BABU, J. MOSES;
RAO, B. VENKATESWARA;
DOUGLAS, S. PAUL

Publication type:

Article

Isolation, Identification, and Characterisation of Degradation Products and the Development and Validation of a Stability-Indicating Method for the Estimation of Impurities in the Tolterodine Tartrate Formulation.

Published in:

Scientia Pharmaceutica, 2015, v. 83, n. 1, p. 65, doi. 10.3797/scipharm.1407-18

By:

PRAKASH, Lakkireddy;
HIMAJA, Malipeddi;
VASUDEV, Rudraraju

Publication type:

Article

A New Rapid and Sensitive Stability-Indicating UPLC Assay Method for Tolterodine Tartrate: Application in Pharmaceuticals, Human Plasma and Urine Samples.

Published in:

Scientia Pharmaceutica, 2012, v. 80, n. 1, p. 101, doi. 10.3797/scipharm.1110-14

By:

Yanamandra, Ramesh;
Vadla, Chandra Sekhar;
Puppala, Umamaheshwar;
Patro, Balaram;
Murthy, Yellajyosula. L. N.;
Ramaiah, Parimi Atchuta

Publication type:

Article

Prominent Complaint: a Guide to Medical Therapy of Overactive Bladder Syndrome in Older Women.

Published in:

Acta Medica Iranica, 2015, v. 53, n. 2, p. 125

By:

Jafarabadi, Mina;
Ghanbari, Zinat;
Hashemi, Shahrzad;
Nemati, Maryam;
Haghollahi, Fedyeh;
Nekoo, Elham Azimi

Publication type:

Article

Formulation development and evaluation of modified oral drug delivery system of tolterodine tartrate microsponges.

Published in:

Journal of Research in Pharmacy, 2022, v. 26, n. 5, p. 1138, doi. 10.29228/jrp.209

By:

Gade, Ramani;
Nama, Sreekanth;
Avula, Prameela Rani

Publication type:

Article

Steroid Dependent Nephrotic Syndrome with Vesicoureteral Reflux.

Published in:

Asian Journal of Pediatric Nephrology, 2022, v. 5, n. 2, p. 95, doi. 10.4103/ajpn.ajpn_11_22

By:

Acharya, Suchi;
John, Biju M.

Publication type:

Article

Publicly funded overactive bladder drug treatment patterns in Ontario over 15 years: An ecological study.

Published in:

Canadian Urological Association Journal, 2018, v. 12, n. 3, p. E142, doi. 10.5489/cuaj.4541

By:

Tadrous, Mina;
Elterman, Dean;
Wayne Khuu;
Mamdani, Muhammad M.;
Juurlink, David N.;
Gomes, Tara

Publication type:

Article

Double anticholinergic therapy for refractory neurogenic and nonneurogenic detrusor overactivity in children: Long-term results of a prospective open-label study.

Published in:

Canadian Urological Association Journal, 2014, v. 8, n. 5/6, p. 175, doi. 10.5489/cuaj.1362

By:

Nadeau, Geneviève;
Schröder, Annette;
Moore, Katherine;
Génois, Lucie;
Lamontagne, Pascale;
Hamel, Micheline;
Pellerin, Ève;
Bolduc, Stéphane

Publication type:

Article

Moderated Poster Session IV: Basic Science & Education Friday, November 1,2013 10:45 AM -12:30 PM.

Published in:: 2013
Publication type:: Abstract

Population pharmacokinetics of the 5-hydroxymethyl metabolite of tolterodine after administration of fesoterodine sustained release tablet in western and east Asian populations.

Published in:

Journal of Clinical Pharmacology, 2014, v. 54, n. 8, p. 928, doi. 10.1002/jcph.274

By:

Oishi, Masayo;
Tomono, Yoshiro;
Yamagami, Hidetomi;
Malhotra, Bimal

Publication type:

Article

Effects of Hepatic Dysfunction on the Single-Dose Pharmacokinetics of Fesoterodine.

Published in:

Journal of Clinical Pharmacology, 2011, v. 51, n. 3, p. 397, doi. 10.1177/0091270010365547

By:

de Mey, Christian;
Mateva, Lyudmila;
Krastev, Zahariy;
Sachse, Richard;
Wood, Nolan;
Malhotra, Bimal

Publication type:

Article

Statistically optimised ethosomes for transdermal delivery of tolterodine tartrate.

Published in:

Pakistan Journal of Pharmaceutical Sciences, 2013, v. 26, n. 6, p. 1117

By:

D., Prasanthi;
Lakshmi, P. K.

Publication type:

Article

CNE SERIES. Demystifying Nocturia: Identifying the Cause and Tailoring the Treatment.

Published in:

Urologic Nursing, 2010, v. 30, n. 5, p. 276, doi. 10.7257/1053-816X.2010.30.5.276

By:

Laureanno, Paula;
Ellsworth, Pamela

Publication type:

Article

Overactive bladder: Special considerations across a woman's life span.

Published in:

Contemporary OB/GYN, 2018, v. 63, n. 1, p. 21

By:

YEH, JUDY;
CHAI, TOBY C.

Publication type:

Article

The Antimuscarinic Agent Tolterodine Regulates Bladder Extracellular Matrix in Partial Bladder Outlet Obstruction in Rats.

Published in:

Cellular Physiology & Biochemistry (Karger AG), 2018, v. 46, n. 1, p. 36, doi. 10.1159/000488407

By:

Yang, Tong-Xin;
Luo, De-Yi;
Lin, Yi-Fei;
Liu, Qiang;
Cai, Xiang;
Ai, Jian-Zhong;
Li, Hong;
Shen, Hong;
Wang, Kun-Jie

Publication type:

Article

Benign Prostat Hiperplazisinde Tolterodin ve Tamsulosin Kombinasyonunun Semptomlar ve Mesane Çlkam Obstrüksiyonu Üzerine Etkisi.

Published in:

Journal of Turgut Ozal Medical Center, 2013, v. 20, n. 1, p. 12, doi. 10.7247/jtomc.20.1.4

By:

Güzel, Özet;
Öztekin, Çetin Volkan;
Sungur, Mustafa;
Uğurlu, Özgür;
Doluoğlu, Ömer Gökhan;
Yılmaz, Nasır;
Çetinkaya, Mesut

Publication type:

Article

Persistence with first line anticholinergic medication in treatment-naïve overactive bladder patients.

Published in:

Scandinavian Journal of Urology (Taylor & Francis Ltd), 2014, v. 48, n. 1, p. 79, doi. 10.3109/21681805.2013.814707

By:

Krhut, Jan;
Gärtner, Marcel;
Petzel, Martin;
Sykora, Radek;
Nemec, David;
Tvrdik, Josef;
Skoupa, Jana

Publication type:

Article

Green HPLC-Fluorescence detection method for concurrent analysis of Tamsulosin hydrochloride and Tolterodine tartrate in dosage forms and biological fluids.

Published in:

Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-92183-6

By:

Derayea, Sayed M.;
Badr El-Din, Khalid M.;
Ahmed, Ahmed S.;
Oraby, Mohamed;
Abdelshakour, Mohamed A.

Publication type:

Article

Comparing the Efficacy of Tolterodine and Gabapentin Versus Placebo in Catheter Related Bladder Discomfort After Percutaneous Nephrolithotomy: A Randomized Clinical Trial.

Published in:

Journal of Endourology, 2018, v. 32, n. 2, p. 168, doi. 10.1089/end.2017.0563

By:

Maghsoudi, Robab;
Farhadi-Niaki, Saeed;
Etemadian, Masoud;
Kashi, Amir H;
Shadpour, Pejman;
Shirani, Asemaneh;
Samadinezhad-Khoshbaf-Sorkhabi, Rana;
Tabatabaei, Meghdad

Publication type:

Article

Comparison of the Efficacy of Tolterodine versus Oxybutynin in the Treatment of Children with Desmopressin-Resistant Enuresis: A Randomized Controlled Clinical Trial.

Published in:

Ethiopian Journal of Health Sciences, 2023, v. 33, n. 4, p. 611, doi. 10.4314/ejhs.v33i4.7

By:

Ezodin, Neda;
Sarouei, MahboubehJafari;
Khademlo, Mohamad;
Milani, Sevda Hashemi;
Yousefi, Sahar;
Mohammadjafari, Hamid

Publication type:

Article

Comparison of micro-radiofrequency therapy and tolterodine for the treatment of newly diagnosed overactive bladder: A retrospective cohort study.

Published in:

Frontiers in Neuroscience, 2023, v. 17, p. 1, doi. 10.3389/fnins.2023.1120843

By:

Min Tang;
Jin Liu;
Chesong Zhao;
Chengming Wang;
Qian Zhang;
Mulong Du;
Xiaoxin Meng;
Pu Li

Publication type:

Article

VALIDATED STABILITY-INDICATING RP-HPLC ASSAY METHOD FOR FESOTERODINE FUMARATE IN PHARMACEUTICAL PRODUCTS.

Published in:

Acta Poloniae Pharmaceutica, 2023, v. 80, n. 1, p. 33, doi. 10.32383/appdr/163015

By:

ÖZBAY, TOLGA;
GURBETOĞLU, GÜLISTAN PELIN;
SARRACOGLU, NAGEHAN;
DOGANAY, ASUMAN AYBEY;
PINARBASLI, ONUR

Publication type:

Article

OPTIMISATION OF TRANSDERMAL GEL FORMULATIONS OF TOLTERODINE TARTRATE BY EXPERIMENTAL DESIGN.

Published in:

Turkish Journal of Pharmaceutical Sciences, 2013, v. 10, n. 2, p. 273

By:

PRASANTHI, D.;
LAKSHMI, P. K.

Publication type:

Article

Enantioselective synthesis of ( R)-tolterodine using lithiation/borylation-protodeboronation methodology.

Published in:

Canadian Journal of Chemistry, 2012, v. 90, n. 11, p. 965, doi. 10.1139/v2012-069

By:

Roesner, Stefan;
Aggarwal, Varinder K.

Publication type:

Article

FDA approval signals more 'homework' on the horizon in trials.

Published in:

Nature Medicine, 2011, v. 17, n. 7, p. 754, doi. 10.1038/nm0711-754b

By:

Waters, Hannah

Publication type:

Article

Comparison of Tolterodine with Estazolam versus Tolterodine alone for the treatment of women with overactive Bladder Syndrome and Nocturia: A non-randomized prospective comparative study.

Published in:

Pakistan Journal of Medical Sciences, 2011, v. 27, n. 4, p. 763

By:

Zheng Yong Yuan;
Chang Xiao He;
Han Hui Wang;
Ying Chuan Huang;
Dong Li;
Shou Yang Ren;
Xue Fei Li;
Hong Shen

Publication type:

Article

Calculation skills: Answers.

Published in:

Nurse Prescribing, 2015, v. 13, n. 10, p. 516, doi. 10.12968/npre.2015.13.10.516

By:

Eggleton, Alison

Publication type:

Article

Drug calculations for urinary incontinence in women.

Published in:

Nurse Prescribing, 2015, v. 13, n. 10, p. 484, doi. 10.12968/npre.2015.13.10.484

By:

Nuttall, Dilyse

Publication type:

Article

Drug therapies for postmenopausal urinary incontinence.

Published in:

Nurse Prescribing, 2015, v. 13, n. 2, p. 80, doi. 10.12968/npre.2015.13.2.80

By:

Bardsley, Alison

Publication type:

Article

MANAGEMENT OF OVERACTIVE BLADDER SYNDROME.

Published in:

Indian Obstetrics & Gynaecology, 2011, v. 1, n. 1, p. 21

By:

Sharma, J. B.;
Shankar, Meenakshi

Publication type:

Article

Characteristics of antimuscarinic responders versus suboptimal responders in a randomized clinical trial of patients with overactive bladder symptoms.

Published in:

2017

By:

Grenabo, Lars;
Herschorn, Sender;
Kaplan, Steven A.;
Cardozo, Linda;
Scholfield, David;
Arumi, Daniel;
Carlsson, Martin;
Chapman, Douglass;
Ntanios, Fady

Publication type:

journal article

Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.

Published in:

Current Medical Research & Opinion, 2009, v. 25, n. 9, p. 2159, doi. 10.1185/03007990903103279

By:

Rebecca G. Rogers;
Gloria Bachmann;
Harriette Scarpero;
Zhanna Jumadilova;
Franklin Sun;
Jon D. Morrow;
Zhonghong Guan;
Tamara Bavendam

Publication type:

Article

Patient-Focused Treatment Decisions in the Management of Overactive Bladder.

Published in:

Journal of Managed Care Medicine, 2022, v. 25, n. 3, p. 37

By:

Ginsberg, David A.

Publication type:

Article

ОСОБЛИВОСТІ ЛІКУВАННЯ ХВОРИХ З ІДІОПАТИЧНИМ ГІПЕРАКТИВНИМ СЕЧОВИМ МІХУРОМ БЕЗ ДЕТРУЗОРНОЇ ГІПЕРАКТИВНОСТІ.

Published in:

Likarska Sprava, 2019, n. 7/8, p. 35, doi. 10.31640/JVD.7-8.2019(5)

By:

ДЕХТЯР, Ю. М.;
КОСТЄВ, Ф. І.;
ЗАЛИВА, К. А.

Publication type:

Article

Tolterodine treatment of women with overactive bladder syndrome: Comparison of night-time and daytime dosing for nocturia.

Published in:

Journal of Obstetrics & Gynaecology Research, 2017, v. 43, n. 11, p. 1719, doi. 10.1111/jog.13438

By:

Tsai, Ko‐Hsin;
Hsiao, Sheng‐Mou;
Lin, Ho‐Hsiung

Publication type:

Article